<code id='545004FADF'></code><style id='545004FADF'></style>
      • <acronym id='545004FADF'></acronym>
      <center id='545004FADF'><center id='545004FADF'><tfoot id='545004FADF'></tfoot></center><abbr id='545004FADF'><dir id='545004FADF'><tfoot id='545004FADF'></tfoot><noframes id='545004FADF'>
      • <optgroup id='545004FADF'><strike id='545004FADF'><sup id='545004FADF'></sup></strike><code id='545004FADF'></code></optgroup>
        5. <b id='545004FADF'><label id='545004FADF'><select id='545004FADF'><dt id='545004FADF'><span id='545004FADF'></span></dt></select></label></b><u id='545004FADF'></u>
          <i id='545004FADF'><strike id='545004FADF'><tt id='545004FADF'><pre id='545004FADF'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / knowledge / comprehensive      
           
     
           
      
          comprehensive 
           
      
           
      
           
       2025-10-01 13:42:02 
   
      
           
      
           
                        
          comprehensive  
          
                                   
                 
                                      author：explore   
                                        
                                      
                                      Page View：43197
                                  
                                    
          
                                   
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images
          Is this the end of the line for the “pharma bro” with the perpetual smirk?
          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.
          advertisement
          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Will the IRA bring competition to the biologics market?
                                
                            
          Next article：  
                                      
                                          How to save PrEP access — and even expand it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles